Jason Silvers, President and CFO of Generate Biomedicines, Inc. ($GENB), bought shares on the open market three times in the last year, totaling $32,000. His most recent purchase occurred on March 2, 2026. These buys rank 3,380th out of 4,983 insiders in our database, well below the average of $1.46 million across 3.3 transactions per insider. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Generate Biomedicines, Inc. | $GENB | Silvers Jason | President & CFO | P | Common Stock | 500 | $16.00 | 1,500.0000 | 0 | 50.00% | 0.00% |
| March 2, 2026 | Generate Biomedicines, Inc. | $GENB | Silvers Jason | President & CFO | P | Common Stock | 500 | $16.00 | 1,500.0000 | 0 | 50.00% | 0.00% |
| March 2, 2026 | Generate Biomedicines, Inc. | $GENB | Silvers Jason | President & CFO | P | Common Stock | 1000 | $16.00 | 1,500.0000 | 0 | 200.00% | 0.00% |
| Feb. 26, 2026 | Generate Biomedicines, Inc. | $GENB | Silvers Jason | President & CFO | A | Stock Option (Right to Buy) | 295608 | $0.00 | 295,608.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Generate Biomedicines, Inc. | $GENB | Silvers Jason | President & CFO | A | Stock Option (Right to Buy) | 274493 | $0.00 | 274,493.0000 | 0 | 9999.99% | 0.00% |